Chromatography market is estimated to witness high growth, owing to increasing adoption of chromatography techniques for drug discovery & advancement in bio analytical testing
Global chromatography market is estimated to be valued at USD 9.5 Bn in 2024, exhibiting a CAGR of 5.1% over the forecast period 2024-2031. Increasing adoption of chromatography techniques in drug discovery processes and advancements in bioanalytical testing boosts demand for chromatography. Furthermore, growing applications of chromatography techniques in proteomics and genomics research also drives the market growth.
Market Dynamics:
Global chromatography market growth is primarily driven by increasing adoption of chromatography techniques for drug discovery and bioanalytical testing. Chromatography techniques such as high-performance liquid chromatography (HPLC) and gas chromatography (GC) are widely used in drug discovery for separation, identification and quantification of compounds from chemical or biological samples. Moreover, chromatography is used in bioanalytical testing during drug development processes for quantitative determination of drugs and metabolites in biological samples. These widespread applications boosts demand for chromatography instruments and consumables. Growing governmental funding for pharmaceutical and biomedical research can also drive the market growth during the forecast period.
Increased Demand from Pharmaceutical and Biotechnology Industries
The pharmaceutical and biotechnology industries have witnessed significant growth over the past decade. As drug development has become more complex, there has been need for advanced analytical tools to separate, identify and purify drug compounds. Chromatography techniques such as HPLC, GC and LC-MS have become essential tools in drug discovery, drug quality control testing and clinical trials. Their high resolution, reproducibility and precision makes them ideally suited for applications across the drug development lifecycle. Increasing R&D expenditure and streamlining of drug development processes by pharmaceutical companies can boost adoption of chromatography instruments and consumables.
Rising Food Safety Concerns Boosts Demand for Chromatography in the Food and Beverage Industry
Food quality and safety has become a top priority for consumers as well as regulatory agencies worldwide. Chromatography techniques detect adulteration, verify ingredients and identify toxins and allergens in food products. GC and LC methods are commonly used for pesticide residue analysis, mycotoxin detection and evaluation of food authenticity. Chromatography is also employed for testing food supplements, ensuring the claimed ingredients are present in the right proportions. With growing health awareness and stringent safety regulations, food producers are investing more in chromatography-based testing.
High Instrument Costs
Chromatography instruments such as GC, LC and MS systems are highly sophisticated devices comprising precise mechanical parts, advanced electronics and dedicated software. These require recurring expenditures for consumables, maintenance and technical support. The high initial capital required for setting up a chromatography setup is a major financial hurdle, especially for small labs and companies. Even larger players may postpone or forgo upgrades due to budget constraints. Refurbished or rented instruments are an alternative but lack the advantages of new technologies. This price sensitivity restricts the adoption of chromatography, particularly in cost-sensitive regions and applications. The high costs associated with instrumentation, consumables and aftersales services hampers the global chromatography market growth.
Lack of Skilled Professionals
As chromatography techniques have become mainstream in analytical labs, not every laboratory has experts proficient in all aspects of the methodology. Operation, method development, data analysis and troubleshooting of chromatography systems require specialized training. However, trained chromatography specialists commanding high salaries are not easily available everywhere. Frequent technology updates necessitate continuous education. This technical expertise gap discourages some end users from taking full advantage of the technique. It also creates a dependency on equipment vendors. The lack of adequately skilled chromatography workforce restricts its applications and aftermarket services.
Advancements in Column Technology
Column technology is witnessing tremendous innovations that expands the capabilities of chromatographic separation. New stationary phase chemistries tailored for challenging sample matrices augur well for previously intractable applications. Monolithic columns provide faster analysis at high resolution. Integrated column-detector combinations deliver lab-on-a-chip solutions. Modified surfaces enable capture and release of specific analytes. These evolving column formats suitable for high-throughput and automated workflows offer novel opportunities in proteomics, metabolomics and process analysis.
Growth of Omics Technologies Boosts Demand for Chromatography
Omics fields such as proteomics, metabolomics, lipidomics and glycomics involve complex biological samples requiring sophisticated separation techniques. LC and LC-MS have emerged as workhorse platforms for large-scale omics analysis in drug R&D, biomarker discovery, food testing and personalized medicine. The constant refinement of multi-omic analytical methods leverages the high peak capacity and ease-of-use benefits of modern chromatography systems. Moreover, dedicated omics software solutions help optimize experimental designs and extract maximum insights from high-dimensional datasets. The expanding scope and importance of omics technologies in life sciences within pharmaceutical, clinical and academic research applications can offer growth opportunities for global chromatography market.
Link: https://www.coherentmarketinsights.com/market-insight/chromatography-market-4072
Key Developments
- In June 2024, Sartorius introduced the latest addition to its Arium Mini series with the launch of Arium Mini Extend. This new ultrapure laboratory water purification system from the Germany-based company offers enhanced flexibility and convenience. It is specifically designed to fulfill the Type 1 water requirements essential for laboratories engaged in general, life science, and analytical applications.
- In June 2022, Agilent Technologies, a global company that provides instruments, software, services, and consumables for laboratories, introduced new quadrupole mass spectrometers for both liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS). These systems incorporate enhanced instrument intelligence and advanced diagnostic capabilities, aiming to maximize system uptime and efficiency for customers.
- In June 2022, PerkinElmer, Inc., a global corporation, launched the GC 2400 Platform, an advanced solution integrating automated gas chromatography (GC), headspace sampling, and GC/mass spectrometry (GC/MS). This platform is designed to streamline laboratory operations, deliver precise analytical results, and enable flexible monitoring capabilities.
- In March 2020, Thermo Scientific, a life science and clinical research company, Vanquish Core HPLC Systems build upon the acclaimed Vanquish platform to offer a productivity boost tailored for routine laboratories in pharmaceutical, food, and industrial sectors. These systems feature innovations such as the Vanquish Solvent Monitor for automatic solvent and waste level monitoring, alongside continuous background system health checks. This ensures consistent throughput and reliable results, making it an ideal choice to optimize routine testing and quality control workflows, regardless of operator experience.
Key Players: Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Hitachi Ltd., Merck KGAA, PerkinElmer, Inc., Restek Corporatio, Shimadzu Corporation, Thermo Fisher Scientific, Inc., Waters Corporation., Gilson Inc., Young Lin Instrument Co., Ltd, Phenomenex, Restek Corporation, Tosoh Bioscience
